TV personality Suze Orman says don't dream about retiring a minute before you hit 70, while Twitter showman and blogger "Mr. Money Mustache" is promoting a lifestyle through the FIRE movement – which stands for "Financial Independence, Retire Early" – which might enable you to leave your day job by your 30s or 40s.
Join the FIRE movement? Or prepare to burn out by working eight years beyond a solid retirement age?
Unfortunately, it's one extreme or another to snag a sound bite.
Magic numbers do drive blogs and podcastsLet's face it, if you're trying to build a huge following why not create a cash cult based on the idea of retiring young.
Hot Biotech Stocks For 2022: Envestnet, Inc(ENV)
Envestnet, Inc., incorporated on February 11, 2004, is a provider of financial and wealth management technology and services to financial advisors, investors and financial service providers. The Company's segments are Envestnet and Envestnet/Yodlee. Its Envestnet segment provides unified wealth management software and services empowering financial advisors and institutions. Its Envestnet/Yodlee segment is a data aggregation and data analytics platform. The Company's services and related technology are provided through Envestnet's wealth management software, Envestnet/PMC, Envestnet/Tamarac, Vantage Reporting Solution, Envestnet/WMS, Envestnet/Placemark, Envestnet/Retirement Solutions, Envestnet/Yodlee and Envestnet/Finance Logix. The Company operates approximately five Registered Investment Advisors (RIAs) and a registered broker-dealer.
Envestnet
The Company's Envestnet segment works with both RIAs, as well as advisors associated with financial institutions, such as broker-dealers and banks. The Company's centrally-hosted technology platform services include risk assessment and selection of investment strategies and solutions, asset allocation models, research and due diligence, portfolio construction, proposal generation and paperwork preparation, model management and account rebalancing, account monitoring, customized fee billing, overlay services covering asset allocation, tax management and socially responsible investing, aggregated multi-custodian performance reporting and communication tools, as well as access to a range of third-party asset custodians. The Company's Envestnet/Advisor Suite unifies the applications and services advisors use to manage their practice and advise their clients, including financial planning; capital markets assumptions; asset allocation guidance; research and due diligence on investment managers and funds; portfolio management trading and rebalancing; multi-custodial, aggregated performance reporting, and billing calculation and administrat! ion. The Company's portfolio management consultants (PMC) group engages in research and consulting services aimed at providing financial advisors with additional support in addressing their clients' needs, as well as the creation of investment solutions and products. Envestnet/PMC's investment solutions and products include managed account and multi-manager portfolios, mutual fund portfolios and Exchange Traded Fund (ETF) portfolios. Envestnet/PMC also offers Prima Premium Research comprising institutional-quality research and due diligence on investment managers, mutual funds, ETFs and liquid alternatives funds. Its Envestnet/Tamarac provides portfolio accounting, rebalancing, trading, performance reporting and client relationship management (CRM) software. Its Envestnet/Retirement Solutions (ERS) offers a range of services designed specifically for retirement plan professionals. Its Envestnet/Vantage provides enterprise data solutions for financial institutions, aggregates and manages investment data, and provides multi-custodial consolidated performance reporting and benchmarking, giving clients an in-depth view of all holdings, and empowering advisors and institutions to manage their business. Envestnet/Finance Logix provides financial planning and wealth management software solutions to banks, broker-dealers and RIAs. Envestnet/Advisor Now offers private-labeled investor-facing technology that enables advisors and institutions to deliver a digital wealth management experience to their clients.
Envestnet/Yodlee
The Company's Envestnet/Yodlee segment serves two customer groups, financial institutions (FI), customers and Internet services companies, providing financial solutions. Envestnet/Yodlee provides FI customers with access to its platform, open application programming interfaces (APIs) and end user facing applications powered by its platform and APIs (FinApps). Its platform and APIs enable FI customers to receive end user-permissioned transaction data elements that it ! aggregate! s and cleanses, as well as to enable its money movement solutions. The FinApps powered by its platform and APIs can be subscribed to individually or in combinations that include personal financial management, wealth management, card, payments and small-medium business (SMB) solutions. Its YI customers are Internet services companies and third-party developers. Its YI customers operate in a number of sub-vertical markets, including wealth management, personal financial management, small business accounting, small business lending and authentication. These customers use the Envestnet/Yodlee platform to build solutions that leverage its open APIs and access to an end user base. In addition to aggregated transaction-level account data elements, the Company provides YI customers with access to account verification, money movement and risk assessment tools through its APIs. Its YI customers use its solutions in diverse applications, such as providing working capital to small businesses online; personalized financial management, planning and advisory services; e-commerce payment solutions, and online accounting systems for small businesses. The Company provides access to its solutions across multiple channels, including Web, tablet and mobile.
The Envestnet/Yodlee platform a range of FinApps and also enables its customers to develop their own applications through its open APIs, that deliver data, money movement solutions and other feature functionality. Its FinApps are targeted at the retail financial, wealth management, small business, card and other financial solutions sectors. These FinApps help consumers and small businesses manage their finances, review their financial accounts, track their spending, calculate their net worth and perform a range of other activities. Its Expense FinApp helps consumers track their spending and a Payroll FinApp from a third party helps small businesses process their payroll. The Company's technology platforms include Envestnet/Yodlee Data Aggregation and Envestn! et/Yodlee! Money Movement. Its data aggregation platform collects a range of end user-permissioned transaction-level data from over 14,500 sources and puts it in a common repository. Beyond collecting data, its data aggregation platform performs a data refining process and augments the data with additional information from a range of other sources. Its money movement solutions facilitate payment flows. Its customers can debit and credit consumer and small business accounts in real time or in batches and route payments between accounts (funds transfer), to billers (bill pay) or to other individuals (peer to peer). Its payment engine is a task-based payment processing platform that controls all payment activity across cobrands, originators, processors and billers.
The Company competes with SEI Investments Company, AssetMark, Inc., BNY Mellon Corporation, Advent Software, Inc., The Charles Schwab Corporation, Intuit, Inc., Fiserv, Inc., FIS Global Corporation, MicroBilt Corporation and Early Warning Systems, LLC.
Advisors' Opinion:- [By Stephan Byrd]
Fiera Capital Corp decreased its position in Envestnet Inc (NYSE:ENV) by 0.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 637,520 shares of the business services provider’s stock after selling 5,968 shares during the quarter. Fiera Capital Corp owned about 1.39% of Envestnet worth $31,360,000 as of its most recent filing with the Securities and Exchange Commission.
- [By Motley Fool Transcribers]
Envestnet Inc (NYSE:ENV)Q4 2018 Earnings Conference CallFeb. 21, 2019, 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
Hot Biotech Stocks For 2022: Aethlon Medical, Inc.(AEMD)
Aethlon Medical, Inc., incorporated on April 17, 1991, is a medical device company, which creates medical devices to address unmet therapeutic needs in infectious disease, cancer and other life-threatening conditions. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are secreted by tumors to prevent the immune system from rejecting the tumors. Through its majority-owned subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based products to diagnose and monitor neurological disorders and cancer.
In addition, the Company operates under a Department of Defense contract through the Defense Advanced Research Projects Agency (DARPA), related to the development of a sepsis treatment device. The Company also operates under a second Department of Defense contract as a subcontractor. Under these contracts, the Company's tasks include the development of a dialysis-like device to prevent sepsis, a fatal bloodstream infection. The Company is also studying the use of its Hemopurifier as a therapeutic solution against viral pathogens that are not treatable with antiviral drugs, as well as viral pathogens that have evolved to become drug resistant.
The Aethlon Hemopurifier addresses antiviral drug-resistance in Hepatitis C virus and Human Immunodeficiency Virus-infected individuals and serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies. In the Company's clinical studies that are conducted in India, safety and efficacy observations of Hemopurifier therapy have been observed in both Hepatitis C virus and Human Immunodeficiency Virus-infected individuals. Delivery of Hemopurifier therapy can occur thro! ugh the infrastructure of continuous renal replacement therapy and dialysis instruments routinely found in hospitals and clinics. The Hemopurifier is designed to provide a spectrum mechanism to inhibit the presence of certain cancer and infectious disease related particles. Treatment with the Hempurifier lasts from three to six and one half hours in duration. The Company has conducted Hepatitis C virus treatment studies for Aethlon Hemopurifier.
In addition to treating Hepatitis C virus-infected individuals, the Company has conducted a single proof-of-principle treatment study related to the treatment of Human Immunodeficiency Virus. In the study, Hemopurifier therapy reduced viral load by around 93% in a Human Immunodeficiency Virus-Acquired Immunodeficiency Syndrome-infected individual without the administration of antiviral drug therapy.
The Company competes with Asahi Kasei Kurary Medical.
Advisors' Opinion:- [By Shane Hupp]
Get a free copy of the Zacks research report on Aethlon Medical (AEMD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Aethlon Medical (NASDAQ: AEMD) is one of 23 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its competitors? We will compare Aethlon Medical to related businesses based on the strength of its valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership.
- [By Max Byerly]
Aethlon Medical (NASDAQ: AEMD) is one of 23 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its competitors? We will compare Aethlon Medical to related companies based on the strength of its analyst recommendations, valuation, earnings, profitability, institutional ownership, dividends and risk.
Hot Biotech Stocks For 2022: Black Hills Corporation(BKH)
Black Hills Corporation, through its subsidiaries, operates as a diversified energy company in the United States. The company's Electric Utilities segment generates, transmits, and distributes electricity to approximately 207,200 electric customers in South Dakota, Wyoming, Colorado, and Montana; and distributes natural gas to approximately 44,200 gas utility customers in Cheyenne, Wyoming. This segment owns 841 megawatts of generation capacity and 8,703 miles of electric transmission and distribution lines. Its Gas Utilities segment distributes natural gas to approximately 547,300 natural gas utility customers in Colorado, Nebraska, Iowa, and Kansas. This segment owns 645 miles of intrastate gas transmission pipelines and 19,494 miles of gas distribution mains and service lines. The company's Power Generation segment produces electric power and sells the electric capacity and energy primarily to its utilities under long-term contracts. Its Coal Mining segment produces coal at its coal mine located near Gillette, Wyoming and sells the coal to electric generation facilities. The company's Oil and Gas segment explores, develops, and produces crude oil and natural gas primarily in the Rocky Mountain region. This segment's principal assets include the operating interests in the properties in the San Juan basin, the Powder River basin, and the Piceance basin; and non-operated interests in wells located in various states. As of December 31, 2015, it had total reserves of approximately 105 billion cubic feet equivalent of natural gas, crude oil, and natural gas liquids. Black Hills Corporation also provides appliance repair services to approximately 64,000 residential customers; and constructs gas infrastructure facilities and electrical systems for gas transportation and electric utilities customers. The company was founded in 1941 and is headquartered in Rapid City, South Dakota.
Black Hills (NYSE:BKH) Q4 2018 Earnings Conference CallFeb. 8, 2019 11:00 a.m. ET Operator Get a free copy of the Zacks research report on Black Hills (BKH) For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment